Extra-corporeal membrane oxygenation for paediatric respiratory failure

Giles J. Peek, A. W. Sosnowski

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) uses modified cardiopulmonary bypass technology to provide prolonged respiratory or cardiorespiratory support for patients of all ages who have failed conventional intensive care management. The use of ECMO for neonatal respiratory failure is now evidence-based following the publication of the randomised UK Collaborative Trial. ECMO use in children remains more controversial, but overall survival of 71% is possible in a group of moribund patients whose mean PaO2/FlO2 ratio of 61 mmHg accurately predicts death in studies of conventional ventilation. Common diagnoses for children requiring ECMO support are pneumonia and the acute respiratory distress syndrome (ARDS).

Original languageEnglish (US)
Pages (from-to)745-756
Number of pages12
JournalBritish Medical Bulletin
Volume53
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Respiratory Insufficiency
Pediatrics
Membranes
Adult Respiratory Distress Syndrome
Critical Care
Cardiopulmonary Bypass
Ventilation
Publications
Pneumonia
Technology
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Extra-corporeal membrane oxygenation for paediatric respiratory failure. / Peek, Giles J.; Sosnowski, A. W.

In: British Medical Bulletin, Vol. 53, No. 4, 1997, p. 745-756.

Research output: Contribution to journalReview article

Peek, GJ & Sosnowski, AW 1997, 'Extra-corporeal membrane oxygenation for paediatric respiratory failure', British Medical Bulletin, vol. 53, no. 4, pp. 745-756.
Peek, Giles J. ; Sosnowski, A. W. / Extra-corporeal membrane oxygenation for paediatric respiratory failure. In: British Medical Bulletin. 1997 ; Vol. 53, No. 4. pp. 745-756.
@article{dde2d41fce144629b40c0605b2f4af2a,
title = "Extra-corporeal membrane oxygenation for paediatric respiratory failure",
abstract = "Extracorporeal membrane oxygenation (ECMO) uses modified cardiopulmonary bypass technology to provide prolonged respiratory or cardiorespiratory support for patients of all ages who have failed conventional intensive care management. The use of ECMO for neonatal respiratory failure is now evidence-based following the publication of the randomised UK Collaborative Trial. ECMO use in children remains more controversial, but overall survival of 71{\%} is possible in a group of moribund patients whose mean PaO2/FlO2 ratio of 61 mmHg accurately predicts death in studies of conventional ventilation. Common diagnoses for children requiring ECMO support are pneumonia and the acute respiratory distress syndrome (ARDS).",
author = "Peek, {Giles J.} and Sosnowski, {A. W.}",
year = "1997",
language = "English (US)",
volume = "53",
pages = "745--756",
journal = "British Medical Bulletin",
issn = "0007-1420",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Extra-corporeal membrane oxygenation for paediatric respiratory failure

AU - Peek, Giles J.

AU - Sosnowski, A. W.

PY - 1997

Y1 - 1997

N2 - Extracorporeal membrane oxygenation (ECMO) uses modified cardiopulmonary bypass technology to provide prolonged respiratory or cardiorespiratory support for patients of all ages who have failed conventional intensive care management. The use of ECMO for neonatal respiratory failure is now evidence-based following the publication of the randomised UK Collaborative Trial. ECMO use in children remains more controversial, but overall survival of 71% is possible in a group of moribund patients whose mean PaO2/FlO2 ratio of 61 mmHg accurately predicts death in studies of conventional ventilation. Common diagnoses for children requiring ECMO support are pneumonia and the acute respiratory distress syndrome (ARDS).

AB - Extracorporeal membrane oxygenation (ECMO) uses modified cardiopulmonary bypass technology to provide prolonged respiratory or cardiorespiratory support for patients of all ages who have failed conventional intensive care management. The use of ECMO for neonatal respiratory failure is now evidence-based following the publication of the randomised UK Collaborative Trial. ECMO use in children remains more controversial, but overall survival of 71% is possible in a group of moribund patients whose mean PaO2/FlO2 ratio of 61 mmHg accurately predicts death in studies of conventional ventilation. Common diagnoses for children requiring ECMO support are pneumonia and the acute respiratory distress syndrome (ARDS).

UR - http://www.scopus.com/inward/record.url?scp=0030856843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030856843&partnerID=8YFLogxK

M3 - Review article

C2 - 9536525

AN - SCOPUS:0030856843

VL - 53

SP - 745

EP - 756

JO - British Medical Bulletin

JF - British Medical Bulletin

SN - 0007-1420

IS - 4

ER -